Inventor · disambiguated record
Andrew Griffin Sprague
Also filed as: SPRAGUE ANDREW · SPRAGUE ANDREW GRIFFIN
12 granted patents·5 pending applications·3 citations·filing 2007–2023
86Inventor score
Files withALNYLAM PHARMACEUTICALS INC6NOVARTIS AG4ARROWHEAD PHARMACEUTICALS INC3ARROWHEAD RES CORP2DE FOUGEROLLES ANTONIN2
Top patents by PatentIndex Score
17 records- 0181US2024175017A1Complement component c5 irna compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0278US9752152B2Organic compositions to treat beta-ENaC-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2016·Granted Sep 5, 2017·1 cites·15 claims
- 0373US7888498B2Compositions and methods for inhibiting expression of IKK-B geneALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Feb 15, 2011·2 cites·30 claims
- 0471US10550391B2Organic compositions to treat beta-ENaC-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Feb 4, 2020·0 cites·15 claims
- 0569US2022403381A1Complement component c5 irna compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0669US2020032258A1Complement component c5 irna compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0768US10081811B2Organic compositions to treat Beta-ENaC-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Sep 25, 2018·0 cites·15 claims
- 0866US9080175B2Organic compositions to treat Beta-ENaC-related diseasesARROWHEAD RES CORP·Filed 2013·Granted Jul 14, 2015·0 cites·15 claims
- 0964US8598335B2Organic compositions to treat Beta-ENaC-related diseasesDE FOUGEROLLES ANTONIN·Filed 2012·Granted Dec 3, 2013·0 cites·15 claims
- 1063US8344130B2Organic compositions to treat Beta-ENaC-related diseasesNOVARTIS AG·Filed 2012·Granted Jan 1, 2013·0 cites·21 claims
- 1163US8344131B2Organic compositions to treat beta-ENaC-related diseasesNOVARTIS AG·Filed 2012·Granted Jan 1, 2013·0 cites·21 claims
- 1263US8344129B2Organic compositions to treat Beta-ENaC-related diseasesNOVARTIS AG·Filed 2012·Granted Jan 1, 2013·0 cites·17 claims
- 1362US2017253874A1Complement component c5 irna compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1461US9376683B2Organic compositions to treat beta-ENaC-related diseasesARROWHEAD RES CORP·Filed 2015·Granted Jun 28, 2016·0 cites·13 claims
- 1561US8344127B2Organic compositions to treat beta-ENaC-related diseasesNOVARTIS AG·Filed 2011·Granted Jan 1, 2013·0 cites·21 claims
- 1647US9000143B2Compositions and methods for inhibiting expression of IKK-B geneDE FOUGEROLLES ANTONIN·Filed 2010·Granted Apr 7, 2015·0 cites·17 claims
- 1747US2015240242A1Compositions And Methods For Inhibiting Expression Of IKK-B GeneALNYLAM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Griffin Sprague files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →